A novel viral ORFeome proteomics platform has been unveiled, marking a monumental leap in virology by enabling the expansive analysis…
Read More
Moderna bets on mRNA’s second act with cancer, autoimmune programs and AI research platform
At its recent annual Science Day, biotechnology giant Moderna signaled a profound strategic expansion beyond its highly successful infectious disease…
Read More
How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform
In a significant advancement for precision oncology, ConcertAI, a leading AI and real-world data company focused on cancer care, has…
Read More
Moderna bets on mRNA’s second act with cancer, autoimmune programs and AI research platform
Moderna, the biotechnology firm that gained global prominence for its mRNA-based COVID-19 vaccine, is embarking on a significant strategic pivot,…
Read More
Ginkgo, Tangible and Inductive Bio Launch ADME-One Platform to Revolutionize Early Drug Discovery Decisions with AI and Automation
A significant shift is underway in small-molecule drug discovery, as a new collaboration between Ginkgo Datapoints, Tangible Scientific, and Inductive…
Read More
EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data Platform
The intricate world of pharmaceutical research, particularly the demanding phases of clinical trials, stands at a pivotal juncture. Faced with…
Read More
A novel ‘asthma-on-a-chip’ platform breathes new life into study of the condition, offering hope for future treatments.
Engineers at the University of Pennsylvania (PA, USA) have engineered a groundbreaking human lung-on-a-chip technology, capable of replicating the intricate…
Read More
Bioengineered Bone Marrow Platform Offers New Frontier for Cancer Treatment Drug Testing and Deep Space Exploration
Researchers at the University of Pennsylvania School of Engineering and Applied Science, the Perelman School of Medicine, and the Children’s…
Read More
EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data Platform
The landscape of clinical trials, a critical yet notoriously complex phase in drug development, is on the cusp of a…
Read More
AviadoBio Expands Exclusive Licensing of vMiX Gene-Silencing Platform to Encompass All Human Therapeutic Areas
AviadoBio has significantly broadened its strategic horizons through an expanded exclusive licensing agreement with King’s College London. This pivotal development…
Read More
